Must-Know Finance Concepts for Life Sciences Valuations

This whitepaper introduces the key concepts and most common methodologies used to evaluate life sciences assets.

In this whitepaper you'll learn:


The most common various valuation methodologies

Methodologies used by pharma and venture capitalists 

Three fundamental concepts in valuation

download THE
WHITEPAPER

By supplying my contact information, I authorize ShareVault to contact me about relevant content, products, and services. We're committed to your privacy, for more information, check out our Privacy Policy.

WHITEPAPER AUTHOR:

Company team

Jeff Karan

Co-Founder and Managing Partner of WaveEdge Capital

Jeff brings over 30 years of investment
banking and corporate advisory
experience to WaveEdge Capital.  In
addition to his extensive knowledge
of capital raising and merger &
acquisitions, Jeff has advised clients on corporate strategy, business valuation,
and a wide range of strategic partnership structures. Learn More

Company team

John Selig

Co-Founder and Managing Partner of WaveEdge Capital

John advises life sciences companieson M&A, licensing and financial strategy. Heteaches the valuation and finance module at BIO’s Executive Management course for BD professionals and at Stanford Medical School’s Entrepreneurship program. Learn More


Sponsored by:

vdr demo or biopharma